Outcome Following Use of NaOCl and Chlorhexidine as Wound Lavage Agents
Conditions: Irreversible Pulpitis Interventions: Procedure: sodium hypochlorite lavage; Procedure: Chlorhexidine lavage Sponsors: Postgraduate Institute of Dental Sciences Rohtak Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.
Conditions: Metabolic Acidosis; CKD; Electrolyte and Fluid Balance Conditions Interventions: Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of potassium chloride; Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of potassium gluconate; Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of potassium bicarbonate; Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of sodium chloride; Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of sodium bicarbonate; Dietary Supplement: Placebo caps Sponsors: Erasmus Medical Center Not yet recruiting (...
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery
Conditions: Elective Cesarean Delivery Interventions: Drug: Calcium Gluconate 10%; Drug: sodium chloride 0.9% Sponsors: Rambam Health Care Campus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery
Conditions: Spinal Fusion; Spine Disease; Spinal Stenosis; Erector Spinae Plane Block Interventions: Drug: 0.9% Sodium Chloride Injection; Drug: Dexamethasone 4 Mg/mL Injectable Solution; Drug: Dexmedetomidine injection Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty
Conditions: Hip Osteoarthritis; Hip Arthropathy; Hip Pain Chronic Interventions: Drug: 0.9%sodium chloride; Drug: Dexamethasone; Drug: Dexmedetomidine Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Dexamethasone vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery
Conditions: Foot Injuries and Disorders; Ankle Injuries and Disorders Interventions: Drug: 0.9%sodium chloride; Drug: Dexamethasone; Drug: Dexmedetomidine Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Toothpaste With Sodium Carbonate in Patients With Gingivitis
Conditions: Gingivitis; Periodontal Diseases Interventions: Drug: Toothpaste Product Sponsors: University of Catania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury
Conditions: Sepsis; Liver Dysfunction Interventions: Drug: Mecobalamin; Drug: Ceftriaxone Sodium; Drug: Saline; Drug: Placebo Sponsors: Sichuan Provincial People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
The Effect of Renastart Formula Supplementation in Children With Acute Kidney Injury in Maintaining Normal Serum Electrolytes Levels
Conditions: Acute Kidney Injury Interventions: Dietary Supplement: Renastart formula; Drug: calcium carbonate (phosphorus binder) with / or sodium polystyrene sulfonate (potassium binder) with dosage 0.5-1mg/kg/day orally. Sponsors: Ain Shams University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19
Conditions: ARDS Due to Disease Caused by SARS Co-V-2 Interventions: Drug: Sivelestat sodium; Drug: Control Sponsors: The First Hospital of Jilin University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Conditions: Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery Interventions: Drug: SHR-2004; Drug: Enoxaparin Sodium Injection; Rivaroxaban Tablets Sponsors: Beijing Suncadia Pharmaceuticals Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
OnabotulinumtoxinA for Trigeminal Neuralgia
Conditions: Trigeminal Neuralgia Interventions: Drug: OnabotulinumtoxinA 100 UNT [Botox]; Drug: Sodium Chloride 0.9% for Injection, Preservative Free Sponsors: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers
Conditions: Decompression Sickness Interventions: Drug: Sodium Chloride 0.9% Inj pre-exposure; Drug: Sodium Chloride 0.9% Inj post-exposure; Drug: Recombinant human plasma gelsolin pre-exposure; Drug: Recombinant human plasma gelsolin post-exposure; Other: Hyperbaric chamber Sponsors: BioAegis Therapeutics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets
Conditions: Multiple Drug Use Interventions: Drug: Sodium valproate 500 MG; Drug: Valproic Acid 500 MG Sponsors: Desitin Arzneimittel GmbH; BioPharma Services, Inc Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Effect of Sodium and UF Profiling on Dialysis
Conditions: Dialysis; Complications Interventions: Device: Na and ultrafiltration profiling Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
